Why the study?
COPD is recognized as a systemic disease with chronic inflammation and frequent cardiovascular involvement, but associations between oxidative stress-related inflammatory markers and structural and electrical cardiac abnormalities warranted investigation.
Are systemic inflammatory markers associated with structural and electrical cardiac abnormalities in patients with COPD?
Cross-Sectional (n=100)
No
Are systemic inflammatory markers associated with structural and electrical cardiac abnormalities in patients with COPD?
Answers are grounded in this paper and cite their sources.
Systemic inflammatory markers, particularly SII and IL-6, are associated with electrical cardiac abnormalities in COPD patients, suggesting a role in early cardiovascular risk stratification.
Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a systemic disease characterized by chronic inflammation and oxidative stress, with frequent cardiovascular involvement. This study investigated the associations between oxidative stress-related inflammatory markers and structural and electrical cardiac abnormalities in patients with COPD using a comprehensive multimodal cardiopulmonary assessment. A total of 100 clinically stable patients with COPD underwent inflammatory biomarker evaluation (IL-6, IL-8, IL-1β, and TNF-α), transthoracic echocardiography and 24 h Holter ECG monitoring. Advanced COPD was associated with significant differences in several structural cardiac parameters, including left atrial volume (p = 0.016), left atrial height (p = 0.027), and selected left ventricular parameters, while left ventricular ejection fraction remained preserved. Electrical abnormalities were significantly associated with systemic inflammatory markers. SII showed the highest discriminatory performance for sinus rhythm abnormalities (AUC = 0.736), whereas IL-6 showed the highest discriminatory performance for ventricular premature complexes (AUC = 0.732). Ventricular ectopic activity was also associated with significantly higher SII, SIRI, MLR, NLR, and PLR. Systemic inflammatory markers were associated with structural and electrical cardiac abnormalities in COPD, suggesting that they may provide complementary information regarding cardiovascular involvement. However, given the cross-sectional design and moderate discriminatory performance of these biomarkers, the findings should be considered exploratory and do not establish causal relationships. Prospective studies are needed to determine their potential role in cardiovascular risk stratification.
No takes yet. Share an insight, caveat, or question.
Moaleș et al. (2026) conducted a cross-sectional in Chronic obstructive pulmonary disease (COPD) (n=100). Systemic inflammatory markers (e.g., SII, IL-6) vs. Patients without specific arrhythmias or lower inflammatory marker levels was evaluated on Sinus rhythm abnormalities on 24 h Holter monitoring (AUC 0.736, p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: